{
    "page": {
        "original_image_path": "/mnt/sh_flex_storage/home/zehanyu/repos/GPT-Paper/pdfs/cancer_review/Artificial Intelligence in Hepatology Ready for the Primetime/pages/page_12.png",
        "current_image_path": "/mnt/sh_flex_storage/home/zehanyu/repos/GPT-Paper/pdfs/cancer_review/Artificial Intelligence in Hepatology Ready for the Primetime/pages_ordered/page_12.png",
        "image_width": 2481,
        "image_height": 3308,
        "regions_num": 2,
        "page_idx": 12
    },
    "regions": [
        {
            "idx": 1,
            "thing": "list",
            "score": 98.25,
            "box": [
                205.1,
                352.7,
                1204.6,
                3000.5
            ],
            "crop_image_path": "/mnt/sh_flex_storage/home/zehanyu/repos/GPT-Paper/pdfs/cancer_review/Artificial Intelligence in Hepatology Ready for the Primetime/crops_ordered/page_12/region_1_list.png",
            "text": "3. Colom R, Karama 3s, Jung Rr, Haler RJ. Human intelligence and\nbrain networks. Dialogues Clin Neurosci. 2010;12:489-501.\n\n4. Michie D, Spiegelhalter DJ, Taylor CC. Machine Learning, Neural\nand Statistical Classification. 1994.\n\n5. Sathya R, Abraham A. Comparison of supervised and unsupervised\nlearning algorithms for pattern classification. Int J Adv Res Artif In-\ntell. 2013;2:34-38.\n\n6. LeCun Y, Bengio Y, Hinton G. Deep learning. Nature.\n2015;521:436-444.\n\n7. Zhou L-Q, Wang J-Y, Yu S-Y, et al. Artificial intelligence in medical\nimaging of the liver. World J Gastroenterol. 2019;25:672.\n\n8. Le Berre C, Sandborn WJ, Aridhi S, et al. Application of artificial in-\ntelligence to gastroenterology and hepatology. Gastroenterology.\n2020;158:76-94. e2.\n\n9. Hu W, Yang H, Xu H, Mao Y. Radiomics based on artificial intelli-\ngence in liver diseases: where are we? Gastroenterol report.\n2020;8:90-97.\n\n10. Lambin P, Leijenaar RT, Deist TM, et al. Radiomics: the bridge be-\ntween medical imaging and personalized medicine. Nat Rev Clin\nOncol. 2017;14:749-762.\n\n11. Pinker K, Shitano F, Sala E, et al. Background, current role, and po-\ntential applications of radiogenomics. J Magn Reson Imag.\n2018;47:604-620.\n\n12. Rutman AM, Kuo MD. Radiogenomics: creating a link between mo-\nlecular diagnostics and diagnostic imaging. Eur J Radiol.\n2009;70:232-241.\n\n13. Pannala R, Krishnan K, Melson J, et al. Artificial intelligence in\ngastrointestinal endoscopy. Video. 2020;5:598-613.\n\n14. Lee HW, Sung JJY, Ahn SH. Artificial intelligence in liver disease.\nJ Gastroenterol Hepatol. 2021;36:539-542.\n\n15. Wang D, Wang Q, Shan F, Liu B, Lu C. Identification of the risk for\nliver fibrosis on CHB patients using an artificial neural network\nbased on routine and serum markers. BMC Infect Dis.\n2010;10:251.\n\n16. Wei R, Wang J, Wang X, et al. Clinical prediction of HBV and HCV\nrelated hepatic fibrosis using machine learning. EBioMedicine.\n2018;35:124-132.\n\n17. Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than\npictures, they are data. Radiology. 2016;278:563-577.\n\n18. Chen Y, Luo Y, Huang W, et al. Machine-learning-based classifica-\ntion of real-time tissue elastography for hepatic fibrosis in patients\nwith chronic hepatitis B. Comput Biol Med. 2017;89:18-23.\n\n19. Wang K, Lu X, Zhou H, etal. Deep learning Radiomics of shear wave\nelastography significantly improved diagnostic performance for as-\nsessing liver fibrosis in chronic hepatitis B: a prospective multi-\ncentre study. Gut. 2019;68:729-741.\n\n20. Park HJ, Lee SS, Park B, et al. Radiomics analysis of gadoxetic\nacid-enhanced MRI for staging liver fibrosis. Radiology.\n2019;290:380-387.\n\n21. Piscaglia F, Cucchetti A, Benlloch S, et al. Prediction of significant\nfibrosis in hepatitis C virus infected liver transplant recipients by\nartificial neural network analysis of clinical factors. Eur J Gastroen-\nterol Hepatol. 2006;18:1255-1261.\n\n22. Hashem S, Esmat G, Elakel W, et al. Comparison of machine\nlearning approaches for prediction of advanced liver fibrosis in\nchronic hepatitis C patients. IEEE ACM Trans Comput Biol Bioinf.\n2017;15:861-868.\n\n23. Konerman MA, Zhang Y, Zhu J, Higgins PD, Lok AS, Waljee AK.\nImprovement of predictive models of risk of disease progression\nin chronic hepatitis C by incorporating longitudinal data. Hepatol-\nogy. 2015;61:1832-1841.\n\n24. Konerman MA, Beste LA, Van T, et al. Machine learning models to\npredict disease progression among veterans with hepatitis C virus.\nPLoS One. 2019;14e0208141.\n"
        },
        {
            "idx": 2,
            "thing": "list",
            "score": 98.8,
            "box": [
                1277.6,
                352.4,
                2280.7,
                2999.6
            ],
            "crop_image_path": "/mnt/sh_flex_storage/home/zehanyu/repos/GPT-Paper/pdfs/cancer_review/Artificial Intelligence in Hepatology Ready for the Primetime/crops_ordered/page_12/region_2_list.png",
            "text": "25. Takayama T, Ebinuma H, Tada ยง, et al. Prediction of effect of pegy-\nlated interferon alpha-2b plus ribavirin combination therapy in pa-\ntients with chronic hepatitis C infection. PLoS One.\n2011;6e27223.\n\n26. Sowa J-P, Atmaca 0, Kahraman A, et al. Non-invasive separation of\nalcoholic and non-alcoholic liver disease with predictive modeling.\nPLoS One. 2014;9e101444.\n\n27. Vanderbeck S, Bockhorst J, Komorowski R, Kleiner DE, Gawrieh S.\nAutomatic classification of white regions in liver biopsies by super-\nvised machine learning. Hum Pathol. 2014;45:785-792.\n\n28. Heinemann F, Birk G, Stierstorfer B. Deep learning enables\npathologistlike scoring of NASH models. Sci Rep.\n2019;918454.\n\n29. Sowa J-P, Heider D, Bechmann LP, Gerken G, Hoffmann D,\nCanbay A. Novel algorithm for non-invasive assessment of fibrosis\nin NAFLD. PLoS One. 2013;8e62439.\n\n30. Yip TF, MaA, Wong VS, et al. Laboratory parameter-based machine\nlearning model for excluding non-alcoholic fatty liver disease\n(NAFLD) in the general population. Aliment Pharmacol Ther.\n2017;46:447-456.\n\n31. Application of machine learning methods to predict non-alcoholic\nsteatohepatitis (NASH) in non-alcoholic fatty liver (NAFL) patients.\nIn: Fialoke S, Malarstig A, Miller MR, Dumitriu A, eds. AMIA Annual\nSymposium Proceedings. American Medical Informatics Associa-\ntion; 2018.\n\n32. A novel computer-aided diagnosis framework using deep learning\nfor classification of fatty liver disease in ultrasound imaging. In:\nReddy DS, Bharath R, Rajalakshmi P, eds. 2018 /JEEE 20th Interna-\ntional Conference on E-Health Networking, Applications and Ser-\nvices (Healthcom). IEEE; 2018.\n\n33. Yu Y, Wang J, Ng CW, et al. Deep learning enables automated\nscoring of liver fibrosis stages. Sci Rep. 2018;8:1-10.\n\n34. Arjmand A, Angelis CT, Christou V, et al. Training of deep convolu-\ntional neural networks to identify critical liver alterations in histopa-\nthology image samples. Appl Sci. 2020;10:42.\n\n35. Vall A, Sabnis Y, Shi J, Class R, Hochreiter S, Klambauer G. The\npromise of Al for DILI prediction. Front Artif Intell. 2021;4:15.\n\n36. Ringe KI, Vo Chieu VD, Wacker F, et al. Fully automated detection of\nprimary sclerosing cholangitis (PSC)-compatible bile duct changes\nbased on 3D magnetic resonance cholangiopancreatography using\nmachine learning. Eur Radiol. 2021;31:2482-2489,\n\n37. Eaton JE, Vesterhus M, McCauley BM, et al. Primary sclerosing\ncholangitis risk estimate tool (PRESTo) predicts outcomes of the\ndisease: a derivation and validation study using machine learning.\nHepatology. 2020;71:214-224.\n\n38. Gerussi A, Verda D, Bernasconi DP, et al. Machine learning in pri-\nmary biliary cholangitis: a novel approach for risk stratification.\nLiver Int. 2022;42:615-627.\n\n39. Huang Y, Huang F, Yang L, et al. Development and validation of a\nradiomics signature as a non-invasive complementary predictor\nof gastroesophageal varices and high-risk varices in compensated\nadvanced chronic liver disease: a multicenter study.\nJ Gastroenterol Hepatol. 2021;36:1562-1570.\n\n40. Agarwal S, Sharma S, Kumar M, et al. Development of a machine\nlearning model to predict bleed in esophageal varices in compen-\nsated advanced chronic liver disease: a proof of concept.\nJ Gastroenterol Hepatol. 2021;36:2935-2942,\n\n41. Konerman MA, Lu D, Zhang Y, et al. Assessing risk of fibrosis pro-\ngression and liver-related clinical outcomes among patients with\nboth early stage and advanced chronic hepatitis C. PLoS One.\n2017;12e0187344.\n\n42. Hong W-d, Ji Y-f, Wang D, Chen T-z, Zhu Q-h. Use of artificial neural\nnetwork to predict esophageal varices in patients with HBV related\ncirrhosis. Hepat Mon. 2011;11:544.\n"
        }
    ]
}